ALB and Hyperbilirubinemia: The meta‐analysis results indicated that the use of intravenous albumin administration before exchange transfusion in infants with hyperbilirubinemia resulted in a reduction of total bilirubin by 2.19 (SMD: ‐2.19; 95% CI: ‐4.79, 0.41; I2: 68.03%; p‐heterogeneity > 0.001), with no significant effect (Figure 2).